Komori
Governance4890Tsubota Laboratory IncorporatedPharmaceuticals

Matters Concerning Controlling Shareholders

Disclosed the status of the controlling shareholder and measures to protect minority shareholders in transactions with the controlling shareholder. The company states that it has no transactions with the controlling shareholder.

Worth reading
78Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
60.92
Voting rights ownership percentage (%, total of directly owned and aggregated holdings)
Wording
Definitive
How definitive the wording is.

Governance structure

Controlling shareholder
Tsubota Kazuo46.23%Voting rights

坪田 一男) (controlling shareholder, excluding parent company; voting rights ownership percentage: directly owned 46.23%, included in aggregation 14.69%, total 60.92%

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Changes this time

No changes from the previous report are described.

Governance structure
ItemDetails
Controlling shareholderTsubota Kazuo (坪田 一男) (controlling shareholder, excluding parent company; voting rights ownership percentage: directly owned 46.23%, included in aggregation 14.69%, total 60.92%)
Changes this timeNo changes from the previous report are described.
Items this document does not state (6)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

When conducting transactions with the controlling shareholder, the company’s basic policy is to deliberate and resolve the transaction details, terms and appropriateness at a meeting of the Board of Directors, and to conduct the transactions on the same terms as transactions with third parties. The company states that, as necessary, it will seek the opinions of external experts, including attorneys and accounting auditors, to ensure fairness and protect the rights of minority shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Concerning Controlling Shareholders | Tsubota Laboratory Incorporated (4890) timely disclosure | Komori